Hydromer, Inc. (HYDI)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Hydromer, Inc. (HYDI) trades at $0.22 with AI Score 48/100 (Grade C). Hydromer, Inc. (HYDI) specializes in hydrophilic polymer-based solutions, focusing on medical and cosmetic applications. Market cap: $1.05M, Sector: Basic materials.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for HYDI: HYDI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HYDI against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
HYDI: the 1 perspectives are evenly split.
How is this calculated? →Hydromer, Inc. (HYDI) Materials & Commodity Exposure
Hydromer, Inc. (HYDI) is a leader in hydrophilic polymer-based solutions, offering specialized products and services across medical and cosmetic sectors, with a strong focus on innovation and patenting.
What Is the Investment Thesis for HYDI?
Hydromer, Inc. (HYDI) presents a unique value proposition in the specialty chemicals sector, driven by its innovative hydrophilic polymer solutions. The company's focus on medical products, particularly specialized coatings and hydrogels, positions it well within the growing healthcare market. As the demand for advanced medical coatings increases, driven by trends in minimally invasive procedures and personalized medicine, Hydromer is poised for growth. Additionally, the cosmetics and personal care market, which is projected to reach $800 billion by 2025, offers further opportunities for expansion. With a gross margin of 48.9%, significantly above industry averages, Hydromer demonstrates strong operational efficiency. However, the company faces challenges, including a negative profit margin of -42.8%, which could impact its financial stability if not addressed. Investors should monitor the company's ability to leverage its innovative capabilities to drive revenue growth and improve profitability in the coming years.
Based on FMP financials and quantitative analysis
HYDI Key Highlights
- Market Cap: $0.00B, indicating potential for growth as the company expands its product lines.
- Profit Margin: -42.8%, highlighting current financial challenges that need addressing.
- Gross Margin: 48.9%, which exceeds many competitors in the specialty chemicals sector.
- Beta: -0.59, suggesting lower volatility compared to the broader market.
- No dividend yield, indicating a focus on reinvestment for growth.
Who Are HYDI's Competitors?
HYDI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AVY Avery Dennison Corporation | $165.33 | -0.98% | $12.65B | 65 |
| HUN Huntsman Corporation | $10.51 | -2.83% | $1.84B | 42 |
| SHW The Sherwin-Williams Company | $348.17 | -1.22% | $85.87B | 78 |
| PPG PPG Industries, Inc. | $123.65 | -1.34% | $27.56B | 86 |
| HGRAF HydroGraph Clean Power Inc. | $3.43 | -3.11% | $1.20B | 69 |
| LWLG Lightwave Logic, Inc. | $7.46 | +1.29% | $1.15B | 69 |
| COOSF Carbios SAS | $6.50 | -9.09% | $109.66M | 69 |
| NVZMY Novozymes A/S | $63.45 | -2.53% | $29.58B | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HYDI's Key Strengths?
- Innovative product offerings in hydrophilic polymers.
- Strong expertise in medical and cosmetic applications.
- Established reputation for quality and reliability.
- Diverse customer base across multiple industries.
What Are HYDI's Weaknesses?
- Negative profit margin indicating financial challenges.
- Limited workforce may constrain growth potential.
- Dependence on niche markets could pose risks.
- Lack of brand recognition compared to larger competitors.
What Are the Key Risks for HYDI?
- Financial-distress signal — its Altman Z-Score of -1.91 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
What Are the Growth Opportunities for HYDI?
- Growth opportunity 1: The global medical coatings market is expected to reach $20 billion by 2025, driven by the increasing demand for advanced medical devices and minimally invasive procedures. Hydromer's expertise in specialized medical coatings positions it to capture significant market share, particularly as healthcare providers seek innovative solutions to enhance patient outcomes.
- Growth opportunity 2: The cosmetics and personal care market is projected to grow to $800 billion by 2025, with a rising demand for unique and effective formulations. Hydromer's ability to provide key ingredients for cosmetic products allows it to tap into this expanding market, especially as consumers increasingly prioritize quality and performance in their personal care products.
- Growth opportunity 3: The demand for anti-fog and anti-frost coatings is on the rise, particularly in automotive and consumer goods sectors. As more industries seek to improve visibility and safety, Hydromer's advanced coating technologies can meet these needs, potentially opening new revenue streams and partnerships.
- Growth opportunity 4: Hydromer's engineering and contract coating services offer a pathway for diversification and revenue growth. By leveraging its expertise to provide tailored solutions for various industries, the company can expand its customer base and enhance its service offerings, driving additional sales.
- Growth opportunity 5: The animal health sector is increasingly investing in innovative solutions, with a focus on improving the quality of care and products. Hydromer's capabilities in hydrophilic polymers can be applied to develop specialized products for this market, creating new opportunities for growth and collaboration.
What Opportunities Does HYDI Have?
- Growing demand for advanced medical coatings.
- Expansion potential in the cosmetics and personal care market.
- Increasing need for anti-fog and anti-frost solutions.
- Potential partnerships in the animal health sector.
What Threats Does HYDI Face?
- Intense competition from larger specialty chemicals firms.
- Market volatility impacting demand for products.
- Regulatory changes affecting the chemical industry.
- Economic downturns that could reduce customer spending.
What Are HYDI's Competitive Advantages?
- Strong patent portfolio protecting innovative polymer technologies.
- Expertise in specialized coatings differentiates Hydromer from competitors.
- Established relationships with key players in the medical and cosmetic industries.
- Ability to provide tailored solutions through engineering and contract services.
- Focus on quality and innovation enhances brand reputation.
What Does HYDI Do?
Hydromer, Inc. (HYDI) was founded in 1980 and is headquartered in Branchburg, New Jersey. The company is dedicated to the full lifecycle of hydrophilic polymer-based solutions, encompassing invention, patenting, manufacturing, and global sales of both products and services. Hydromer operates through two primary divisions: Polymer Research and Medical Products. Its diverse offerings include specialized medical coatings and related services, medical hydrogel formulations, and key ingredients for cosmetic products. In addition to these, Hydromer develops advanced coatings for condensation control, specifically anti-fog and anti-frost applications. The company also manufactures various cosmetics and personal care items and provides protective coatings for watercraft hulls. Furthermore, Hydromer extends its expertise through engineering and contract coating services, catering to a broad spectrum of industries, including medical, cosmetics, animal health, and industrial sectors. Over the years, Hydromer has established a reputation for innovation and quality, positioning itself as a trusted partner in the development of specialized polymer solutions. With a workforce of 34 employees, the company continues to leverage its expertise to meet the evolving needs of its diverse customer base.
What Products and Services Does HYDI Offer?
- Invents and develops hydrophilic polymer-based products.
- Offers specialized medical coatings and related services.
- Manufactures medical hydrogel formulations for various applications.
- Provides key ingredients for cosmetic products.
- Develops advanced coatings for condensation control.
- Manufactures cosmetics and personal care items.
- Offers protective coatings for watercraft hulls.
- Extends expertise through engineering and contract coating services.
How Does HYDI Make Money?
- Generates revenue through the sale of specialized polymer products and services.
- Licenses patented technologies to other companies in the medical and cosmetic sectors.
- Provides contract coating services to various industries, enhancing revenue streams.
- Manufactures and sells cosmetics and personal care products directly to consumers and retailers.
- Offers engineering services to develop customized solutions for clients.
What Industry Does HYDI Operate In?
The specialty chemicals industry is experiencing robust growth, driven by increasing demand for innovative materials across various sectors, including healthcare, cosmetics, and industrial applications. Hydromer, Inc. operates within this dynamic landscape, focusing on hydrophilic polymers that cater to the evolving needs of medical and cosmetic markets. The global specialty chemicals market is projected to reach approximately $1 trillion by 2027, with a compound annual growth rate (CAGR) of around 5%. As a player in this industry, Hydromer is well-positioned to capitalize on these trends, particularly in the medical coatings and cosmetic intermediaries segments, where innovation and quality are paramount.
Who Are HYDI's Key Customers?
- Medical device manufacturers seeking advanced coatings.
- Cosmetic companies looking for innovative ingredients.
- Industrial clients requiring specialized coatings for applications.
- Animal health companies focused on improving product quality.
- Direct consumers of cosmetics and personal care items.
Company Profile
Hydromer, Inc. operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Branchburg, US. The company is led by CEO Michael Torti. HYDI has traded publicly since 1999.
F-Score 3/9Financial Health
Hydromer, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.91 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on assets is -55.9%, showing how much profit it generates from its asset base. Its free cash flow yield is -32.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.44 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -153.8%, the inverse of the P/E and a quick read on earnings relative to price.
HYDI Valuation & Market Position
With a $1.05M market cap, Hydromer, Inc. sits in the micro-cap segment of the market. Relative to its peer group, HYDI's quantitative score of 48/100 is below the peer average of 68/100.
HYDI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests management confidence in Hydromer's future prospects, indicating a belief in the company's growth.
- Community sentiment has turned positive as discussions around Hydromer's innovative product lines gain traction, attracting interest from investors.
- The company's advancements in biopolymer technologies are resonating well with sustainability-focused investors, enhancing its market appeal.
- Recent partnerships with key industry players hint at potential revenue growth, further boosting investor optimism.
Bear Case
- Concerns over the company's ability to scale its production capabilities have surfaced, leading to skepticism among some investors.
- Social sentiment has shown mixed reactions, with a portion of the community expressing doubts about the long-term viability of its current business model.
- Recent regulatory challenges in the biopolymer sector could pose risks to Hydromer's operational efficiency and market access.
- Market perception remains cautious as some analysts question the sustainability of recent growth trends, leading to bearish views.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
HYDI Latest News
No recent news available for HYDI.
HYDI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HYDI.
Price Targets
Wall Street price target analysis for HYDI.
HYDI MoonshotScore
What does this score mean?
The MoonshotScore rates HYDI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
HYDI OTC Market Information
HYDI trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
HYDI Basic Materials Stock FAQ
What are the key factors to evaluate for HYDI?
Hydromer, Inc. (HYDI) holds an AI score of 48/100 (low). Not financial advice.
How frequently does HYDI data refresh on this page?
HYDI prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven HYDI's recent stock price performance?
Hydromer, Inc. (HYDI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative product offerings in hydrophilic polymers. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HYDI overvalued or undervalued right now?
Valuing Hydromer, Inc. (HYDI) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying HYDI?
Before investing in Hydromer, Inc. (HYDI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding HYDI to a portfolio?
Key strength of Hydromer, Inc. (HYDI): Innovative product offerings in hydrophilic polymers. Weigh rewards against risks and diversify. Not financial advice.
Can I buy fractional shares of HYDI?
Yes, most major brokerages offer fractional shares of Hydromer, Inc. (HYDI) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track HYDI's earnings and financial reports?
Hydromer, Inc. (HYDI) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for HYDI earnings announcements is recommended.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.